Evidence map›Paper›PMID 37220445›Full record

ReviewCureus2023

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation.

Hriday Shah, Kerollos S Hanna, Harkirat Kaur, Mohammad S Alazzeh, Abhay Thandavaram, Aneeta Channar, Ansh Purohit, Bijay Shrestha, Deepkumar Patel, Lubna Mohammed

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hriday ShahInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Kerollos S HannaGeneral Physician, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Harkirat KaurGeneral Physician, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Mohammad S AlazzehOrthopaedic Surgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Abhay ThandavaramInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Aneeta ChannarInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ansh PurohitInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Bijay ShresthaFamily Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Deepkumar PatelNeurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Lubna MohammedInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
California Institute of Behavioral Neurosciences and Psychology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperthyroidism is a prevalent cause of atrial fibrillation (AF). High cardiac output with low systemic vascular resistance, driven by hyperthyroidism, is associated with a rapid heartbeat, enhanced left ventricular systolic and diastolic function, and a higher incidence of supraventricular tachyarrhythmias. After returning to euthyroid status, hyperthyroidism-induced AF generally spontaneously reverts to sinus rhythm (SR), and a significant number of patients remain in chronic AF and require electrical cardioversion (ECV). After effective cardioversion, the long-term outcome of hyperthyroidism-induced persistent AF is unknown. Early ECV before the antithyroid medication should be explored for hyperthyroidism-induced AF to reduce the risk of thromboembolic consequences. The recurrence rate of AF between Hyperthyroid and Euthyroid Patients after ECV did not significantly differ. This review article compares the recurrence rate of AF as an outcome of ECV in Hyperthyroid induced atrial fibrillation.

Indexed as

atrial fibrillationelectrical cardioversionhyperthyroidismrecurrence ratethromboembolic events

Identifiers

PMID37220445
PMCPMC10200072
OpenAlexW4366774694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.